secwatch.observer — SEC 8-K summary
======================================

Issuer:     Gain Therapeutics, Inc. (GANX)
CIK:        0001819411
Form:       8-K
Filed at:   2025-11-28T23:59:59+00:00
Accession:  0001104659-25-116947
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gain Therapeutics files prospectus supplement for up to $35.5M ATM stock offering
--------------------------------------------------------------------------------

- Prospectus supplement filed for ATM offering of up to $35.5M of common stock via Oppenheimer & Co.
- Company previously sold $14.47M under prior ATM program dated Sept 2024, now updating under new shelf.
- New S-3 registration (333-287622) became effective Nov 26, 2025; supplement dated Nov 28, 2025.
- Proceeds expected for general corporate purposes; legal opinion from Lowenstein Sandler attached.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819411/000110465925116947/0001104659-25-116947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819411/000110465925116947/tm2530369d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-116947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer